Pomegranate fruit as a lung cancer chemopreventive agent

Drugs of the Future

Volumn 32, Issue 6, 2007, Pages 549-554

  Khan, Naghma ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; DRINKING WATER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; N NITROSO TRISCHLOROETHYLUREA; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; POMEGRANATE FRUIT EXTRACT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; DRUG DETERMINATION; DRUG MECHANISM; DRUG SCREENING; ENZYME INHIBITION; FRUIT; HUMAN; LUNG CANCER; NONHUMAN; POMEGRANATE; REVIEW; SIGNAL TRANSDUCTION;

EID: 34547743887     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2007.032.06.1097137     Document Type: Review

References (24)

1. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M.J. Cancer statistics, 2007. CA Cancer J Clin 2007, 57: 43-66.
2. American Cancer Society Surveillance Research. Cancer facts and figures 2004. Atlanta, American Cancer Society, 2004, 1-60.
3. de Nigris, F., Williams-Ignarro, S., Botti, C., Sica, V., Ignarro, L.J., Napoli, C. Pomegranate juice reduces oxidized low-density lipoprotein downregulation of endothelial nitric oxide synthase in human coronary endothelial cells. Nitric Oxide 2006, 15: 259-63.
4. de Nigris, F., Williams-Ignarro, S., Lerman, L.O. et al. Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc Natl Acad Sci USA 2005, 102: 4896-901.
5. Schubert, S.Y., Neeman, I., Resnick, N. A novel mechanism for the inhibition of NF-κB activation in vascular endothelial cells by natural antioxidants. FASEB J 2002, 16: 1931-3.
6. Gil, M.I., Tomas-Barberan, F.A., Hess-Pierce, B., Holcroft, D.M., Kedar, A.A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 2000, 10: 4581-9.
7. Pantuck, A.J., Leppert, J.T., Zomorodian, N. et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 2006, 12: 4018-26.
8. Afaq, F., Saleem, M., Krueger, C.G., Reed, J.D., Mukhtar, H. Anthocyanin and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 2005, 113: 423-33.
9. Malik, A., Afaq, F., Sarfaraz, S., Adhami, V.M., Syed, D.N., Mukhtar, H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 2005, 102: 14813-8.
10. Afaq, F., Malik, A., Syed, D., Maes, D., Matsui, M.S., Mukhtar, H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes. Photochem Photobiol 2005, 81: 38-45.
11. Syed, D.N., Malik, A., Hadi, N., Sarfaraz, S., Afaq, F., Mukhtar, H. Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes. Photochem Photobiol 2006, 82: 398-405.
12. Khan, N., Afaq, F., Mukhtar, H. Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis 2007, 28: 233-9.
13. Caputi, M., Russo, G., Vincenzo, E., Alessandro, M., Giordano, A. J. Role of cell-cycle regulators in lung cancer. J Cell Physiol 2005, 205: 319-27.
14. Wright. J.G., Christman, J.W. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: Implications for therapy. Am J Respir Med 2003, 2: 211-9.
15. Afaq, F., Ahmad, N., Mukhtar, H. Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 2003, 22: 9254-64.
16. Mossman, B.T., Lounsbury, K.M., Reddy, S.P. Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol 2006, 34: 666-9.
17. Tang, J.M., He, Q.Y., Guo, R.X., Chang, X.J. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer 2006, 51: 181-91.
18. Khan, N., Afaq, F., Kweon, M.H., Kim, K.M., Mukhtar, H. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res 2007, 67: 3475-82.
19. Faivre, S., Kroemer, G., Raymond, E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 2006, 5: 671-88.
20. Han, S., Khuri, F.R., Roman, J. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer Res 2006, 66: 315-23.
21. Nathan, C.A., Amirghahari, N., Abreo, F. et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Clin Cancer Res 2004, 10: 5820-7.
22. Hahn-Windgassen, A., Nogueira, V., Chen, C.C., Skeen, J.E., Sonenberg, N., Hay, N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005, 280: 32081-9.
23. Burgering, B.M., Coffer, P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995, 376: 599-602.
24. Motoshima, H., Goldstein, B.J., Igata, M., Araki, E. AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 2006, 574: 63-71.